
Developer of Innovative Drug R&D Platform
September 2024On the 10th day of the month, BioMap and Dabeinong reached a strategic cooperation.The two parties combine BioMap's life science large model xTrimo with over 100 billion parameters and Dabeinong's application scenario advantages in the field of large agricultural biotechnology.Jointly build a large agricultural biotechnology AI model, and jointly create the Zhongguan Village Bio-Manufacturing Innovation Center, focusing on directions such as biosynthesis, gene editing, proteomics, pharmaceutical health, and artificial intelligence+.

Leaders from both sides, including Wang Danyu, Vice President of Dabeinong Group, Heng Shiguo, Minister of the R&D Division, and Deng Yongfu, President of BioMap, delivered speeches on behalf of their respective parties. Key representatives attended the signing ceremony and held discussions.

BioMap, co-founded by Robin Li and Liu Wei in 2020, is a global leader in foundational large models for life sciences. The company's xTrimo platform, a large cross-modal biolanguage model with hundreds of billions of parameters, has achieved leading results in over a hundred life science tasks, providing the industry with powerful AI model-building capabilities. Dabeinong is a leading enterprise in China's agricultural technology sector, with biobreeding at the forefront in China. It is committed to promoting the development of China's modern agriculture through technological innovation, possessing industry-leading bio-manufacturing innovation capabilities and a wealth of application scenarios.
BioMap will form a strong alliance with Dabeinong,Build a large-scale agricultural biotechnology innovation ecosystem, empower the global bio-manufacturing ecosystem chain project, and achieve a commercial closed loop in AI model R&D, AI protein design, pilot testing, scale-up, and industrialization within the large-scale agriculture sector.BioMap will build based on leading AI models and biotechnology,Empower Dabeinong to build an autonomous AI model and an AI bio-manufacturing platform with automated high-throughput dry-wet closed loop, driving technological innovation in the field of large agricultural biotechnology.The development of the cooperation between the two parties will have an important impact on the development of the bio-smart manufacturing industry.
The application scenarios of large AI models in the life sciences field are becoming increasingly diverse, not only effectively resolving the contradiction between limited annotated data and vast exploration spaces, but also driving the development of various aspects within the life sciences industry chain. For instance,Based onBioMap's Large-Scale Cross-Modal Life Science Foundation Model xTrimo, with a scale of billions, can be applied to various scenarios in agricultural science, including enzyme engineering, vaccine antigen design, discovery and modification of disease-resistant and pest-resistant proteins, genomic breeding, and other fields.。
In the future, BioMap will provide professional AI model construction capabilities for different life science application scenarios, continuously empowering industry innovations such as biomanufacturing and driving productivity transformation, ushering in a new era of creation in life sciences.
About BioMap
BioMap, a pioneer in the field of large foundational models for life sciences globally, was founded by Robin Li and Wei Liu in 2020. The company is committed to researching and applying cutting-edge AI and biotechnologies to accelerate innovation in the life sciences. The xTrimo platform, BioMap's large cross-modal biological language model with hundreds of billions of parameters, has achieved leading results in over a hundred life science tasks, offering powerful AI model-building capabilities to the industry. Based on its AI models, BioMap's AIGP (AI Generated Protein) generative protein design platform has successfully achieved de novo design of entirely new non-natural proteins in multiple advanced drug discovery and synthetic biology fields worldwide. Currently, BioMap serves hundreds of users globally, including well-known enterprises and research institutions in areas such as international pharmaceutical companies, leading CDMOs, innovative drugs, synthetic biology, and green technology.
About DBN
Dabeinong Group is an agricultural high-tech enterprise founded by young agricultural intellectuals represented by Dr. Shao Genghuo. Since its establishment in 1993, Dabeinong Group has always adhered to the corporate philosophy of "Strengthening agriculture to serve the country, striving for the first place, and achieving common development," and has been committed to promoting the development of modern agriculture in China through technological innovation. In 2010, Dabeinong Group was listed on the Shenzhen Stock Exchange (stock code: 002385), successfully entering the capital market.
